insights_auto
Why is INO up 3,68%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,69 $
arrow_upward
+3,68%(+0,060) 1D
1,71 $
arrow_upward
+1,18% (+0,020)bedtimeAfter hours
Closed: 18 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,64 $
High
1,71 $
Low
1,56 $
Mkt. cap
316,55 մլն
Avg. vol.
19,92 մլն
Volume
11,64 մլն
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
Open
1,64 $
High
1,71 $
Low
1,56 $
Mkt. cap
316,55 մլն
Avg. vol.
19,92 մլն
Volume
11,64 մլն
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
6 ժամ առաջ
Inovio at Jefferies Global Healthcare Conference: launch begins
News Corp
·
7 ժամ առաջ
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Investing.com
·
16 ժամ առաջ
Inovio submits European approval application for RRP treatment
Yahoo Finance
·
1 օր առաջ
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc